CONCERT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about news in CONCERT PHARMACEUTICALS, INC..

The service is free and you can unsubscribe at any time.

General | People (81) | Filings (241) | Annual reports (3) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001367920

CONCERT PHARMACEUTICALS, INC. is a publicly traded company

Trading symbol: CNCE

News

2017-08-18

How Is Concert Pharmaceuticals, Inc. (NasdaqGM:CNCE) Stacking Up?
JCTY News
Looking at some ROIC (Return on Invested Capital) numbers, Concert Pharmaceuticals, Inc. (NasdaqGM:CNCE)'s ROIC Quality Score is -1.773521.

2017-08-18

Trading Options During Earnings in Concert Pharmaceuticals Inc
CML News
We're going to examine buying and selling out of the money strangles in Concert Pharmaceuticals Inc and find out once and for all what the winning trades have been during earnings releases.

2017-08-14

Concert Pharmaceuticals, Inc. (NasdaqGM:CNCE) Placed in the Hotbed: What Are ...
Clayton News
Concert Pharmaceuticals, Inc. (NasdaqGM:CNCE) boasts a Price to Book ratio of 4.936976. This ratio is calculated by dividing the current share price by the book value per share.

2017-08-11

Concert Pharmaceuticals' (CNCE) CEO Roger Tung on Q2 2017 Results - Earnings ...
Seeking Alpha
Concert Pharmaceuticals' (CNCE) CEO Roger Tung on Q2 2017 Results - Earnings Call Transcript ... Good day, ladies and gentlemen, and welcome to the Concert Pharmaceuticals' Second Quarter 2017 financial results. ... [Indiscernible] that this ...

2017-08-11

Concert Pharmaceuticals Inc (CNCE) Chart Focus With An Eye on The Technicals
The Business Union
Looking further at additional technical indicators we can see that the 14-day Commodity Channel Index (CCI) for Concert Pharmaceuticals Inc (CNCE) is sitting at -65.93. CCI is an indicator used in technical analysis that was designed by Donald Lambert.

2017-08-11

Concert Pharmaceuticals Inc (CNCE) Research Coverage Started at HC Wainwright
BNB Daily (blog)
Concert Pharmaceuticals logo HC Wainwright assumed coverage on shares of Concert Pharmaceuticals Inc (NASDAQ:CNCE) in a research note issued to investors on Monday, July 24th, Marketbeat.
Concert Pharmaceuticals Incorporated (NASDAQ:CNCE)'s Stock Is Sell After More ... - BZ Weekly

2017-08-10

Concert Pharmaceuticals Incorporated (NASDAQ:CNCE)'s Stock Is Sell After More ...
BZ Weekly
Investors sentiment increased to 1.36 in 2016 Q4. Its up 0.36, from 1 in 2016Q3. It improved, as 12 investors sold Concert Pharmaceuticals Inc shares while 21 reduced holdings. 13 funds opened positions while 32 raised stakes. 12.41 million shares or 2 ...

CONCERT PHARMACEUTICALS, INC. address

99 HAYDEN AVENUE
SUITE 500
LEXINGTON
02421

Former name

Former name of this company was CONCERT PHARMACEUTICALS INC, date of change: 2006-06-28.

Earliest known filing

June 2006

Latest known filing

August 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

CONCERT PHARMACEUTICALS, INC. has 241 filings. View CONCERT PHARMACEUTICALS, INC. filings.

Annual Reports

Quarterly Reports

Latest company events

People

We have found 81 people related to CONCERT PHARMACEUTICALS, INC..

Similar companies

CONCERTSBYU COM INC, CONCERTS INC, CONCERTO SOFTWARE INC, Concerto Software (Japan) Corp, CONCERTO NETWORKS INC, Concerto Healthcare, Inc., Concerto Credit Opportunity Fund I, LP, Concert Window, Inc., Concert Wealth Management Inc., CONCERT TECHNOLOGY CORP, CONCERT PRODUCTIONS UK LTD, CONCERT PRODUCTIONS INTERNATIONAL B V, CONCERT NETWORK INC, Concert Network Inc, Concert Group Logistics, LLC, Concert Golf Investors, LLC, CONCERT Global Group, Ltd., Concert Financial, LLC, CONCERT CAPITAL LLC, CONCERT ATLANTA INVESTORS LLC, Concert 64, Inc.